Anti-PARVB/ CGI-56 monoclonal antibody

Anti-PARVB/ CGI-56 antibody for FACS & in-vivo assay

Target products collectionGo to PARVB/PARVB products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-MP1323-Ab-1/ GM-Tg-hg-MP1323-Ab-2Anti-Human PARVB monoclonal antibodyHuman
GM-Tg-rg-MP1323-Ab-1/ GM-Tg-rg-MP1323-Ab-2Anti-Rat PARVB monoclonal antibodyRat
GM-Tg-mg-MP1323-Ab-1/ GM-Tg-mg-MP1323-Ab-2Anti-Mouse PARVB monoclonal antibodyMouse
GM-Tg-cynog-MP1323-Ab-1/ GM-Tg-cynog-MP1323-Ab-2Anti-Cynomolgus/ Rhesus macaque PARVB monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-MP1323-Ab-1/ GM-Tg-felg-MP1323-Ab-2Anti-Feline PARVB monoclonal antibodyFeline
GM-Tg-cang-MP1323-Ab-1/ GM-Tg-cang-MP1323-Ab-2Anti-Canine PARVB monoclonal antibodyCanine
GM-Tg-bovg-MP1323-Ab-1/ GM-Tg-bovg-MP1323-Ab-2Anti-Bovine PARVB monoclonal antibodyBovine
GM-Tg-equg-MP1323-Ab-1/ GM-Tg-equg-MP1323-Ab-2Anti-Equine PARVB monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-MP1323-Ab-1/ GM-Tg-hg-MP1323-Ab-2; GM-Tg-rg-MP1323-Ab-1/ GM-Tg-rg-MP1323-Ab-2;
GM-Tg-mg-MP1323-Ab-1/ GM-Tg-mg-MP1323-Ab-2; GM-Tg-cynog-MP1323-Ab-1/ GM-Tg-cynog-MP1323-Ab-2;
GM-Tg-felg-MP1323-Ab-1/ GM-Tg-felg-MP1323-Ab-2; GM-Tg-cang-MP1323-Ab-1/ GM-Tg-cang-MP1323-Ab-2;
GM-Tg-bovg-MP1323-Ab-1/ GM-Tg-bovg-MP1323-Ab-2; GM-Tg-equg-MP1323-Ab-1/ GM-Tg-equg-MP1323-Ab-2
Products NameAnti-PARVB monoclonal antibody
Formatmab
Target NamePARVB
Protein Sub-locationTransmembrane Protein
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by using flow cytometry with antigen overexpressed cell line. The biofunction of antibodies are validated in cell-based assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-PARVB benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS,ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenProducts DevelopingMulti-species PARVB/ CGI-56 VLP (virus-like particle) (Products Developing)


    Target information

    Target IDGM-MP1323
    Target NamePARVB
    Gene ID29780,170736,362973,715859,481215,101087850,616294,100050839
    Gene Symbol and Synonymsaffixin,CGI-56,D15Gsk1,PARVB
    Uniprot AccessionQ9HBI1
    Uniprot Entry NamePARVB_HUMAN
    Protein Sub-locationTransmembrane Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000188677
    Target ClassificationN/A

    The target: PARVB, gene name: PARVB, also named as CGI-56. This gene encodes a member of the parvin family of actin-binding proteins, which play a role in cytoskeleton organization and cell adhesion. These proteins are associated with focal contacts and contain calponin homology domains that bind to actin filaments. This family member binds to alphaPIX and alpha-actinin, and it can inhibit the activity of integrin-linked kinase. This protein also functions in tumor suppression. Alternative splicing of this gene results in multiple transcript variants. [provided by RefSeq, Aug 2011].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.